To the full analysis
City Therapeutics Stock: Fair Value
CTYThe fair value is an estimate from our model, not a price target.
Daily figure as of 20 Nov 2026
Valuation Signal
not measuredPrice
$18.35
Fair value
not computable
Gap to fair value
no data
No fair value can be calculated for this stock, so the signal follows the valuation grade.
Where the Number Comes From
Earnings × 21.3
no data
Fair value (model)
no data
No fair value can be calculated for this stock from the available figures.
Calculate with your own assumptionsData and Required Disclosures
- ; time horizon around 12 months
- Rated Neutral since 7 Nov 2026
- Price: closing price of 19 Nov 2026
- Data from Financial Modeling Prep (FMP) based on the company's reports, latest fiscal year 2019. MEQIRI calculates the score and fair value itself every night.
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.
